Advertisement

Advertisement

Departments

Advertisement

Advertisement

Nov

11

Today In Oncology

Local Consolidative Therapy Enhances Outcomes With Osimertinib in EGFR-Mutant NSCLC

Final FLAURA2 Analysis Confirms First-Line Benefit of Osimertinib-Chemotherapy in EGFR-Positive NSCLC

Routine AI Assistance May Lead to Loss of Skills in Endoscopists, Study Shows

How to Adapt to the Era of AI and the Changing Interactions With Patients: Lessons From a Low-Resource Setting

HER3-DXd in Patients With Active Brain Metastases From NSCLC and Breast Cancer

Advertisement

© 2025 HSP News Service, L.L.C.